Oramed Pharmaceuticals announces annual shareholder meeting

Reuters2026/08/03 20:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Oramed will hold its 2026 annual stockholders meeting in Jerusalem on Sept. 15, 2026.
Vote scheduled on electing six directors, including Nadav Kidron, Miriam Kidron, Arie Mayer, Yehuda Reznick, Benjamin Shapiro, Daniel Aghion.
Shareholders will also vote on ratifying Kesselman & Kesselman as independent auditor for the year ending Dec. 31, 2026.
Ballot includes a plan to raise the 2019 long-term incentive plan share pool by 3,000,000 to 12,500,000 shares.
Additional items include advisory votes on executive pay, the frequency of future pay votes, and a proposal to adjourn the meeting if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oramed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-084609), on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Oramed Pharmaceuticals announces annual shareholder meeting

You may also like

Crypto prices